IC Glucophage vs. Diabetes Mellitus
Below is a summary of the findings of a clinical study performed by Leonid Tanskiy that investigated the effect of Glucophage IC the Weight loss complex IC.
Research Purpose – to study the effect of Glucophage IC on:
- blood sugar level,
- glycated hemoglobin levels,
- Body Mass Index of patients diagnosed with type 2 diabetes, on the background of the alimentary obesity with a Body Mass Index of 31.0 - 35.9, which corresponds to the second degree of obesity.
The study was conducted in the period from 01.05.2011 to 01.09.2012
In the study 3 men and 3 women took part.
All patients had previously provided written consent for clinical trials. Patients were informed about the possibilities of information medicine.
Before the study, body weight, Body Mass Index, fasting blood sugar level, glycosylated hemoglobin index, biochemical analysis of blood were measured for all patients.
All patients before the study took oral hypoglycemic drugs tablets for 3-6 years:
- 3 patients used 1500 mg of Metformin daily,
- 3 patients used 3 mg of Oltar in the morning before eating.
During the test, all oral hypoglycemic drugs were canceled.
Patients were recommended: strict adherence to diet with the restriction of animal fats, as well as drinking Glucophage IC water four times a day:
- 200 ml before a meal - three times a day
- and 200 ml before sleep
Results of Biochemical Analysis
- The blood glucose level of all 6 patients, who used water with Glucophage IC, does not exceed 7.0 mmol/l, which corresponds to 100% compensation of diabetes mellitus of the second type.
- Glycosylated hemoglobin level decreased by more than 1.5 mmol/l of all 6 patients.
- Taking into consideration that normalization of levels of glycated hemoglobin was observed 4-6 weeks after normalization of blood glucose levels, the achieved effect might be considered as good.
- The average weight loss was 30 kg in 16 months.
- Low blood calcium level in all patients indicates about latent hypothyroidism. It is necessary for all patients with alimentary obesity to examine the level of thyroid hormones, and blood calcium levels.
- All patients did not mention side effects from Glucophage IC.